0001104659-20-097591.txt : 20200821 0001104659-20-097591.hdr.sgml : 20200821 20200821161529 ACCESSION NUMBER: 0001104659-20-097591 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200819 FILED AS OF DATE: 20200821 DATE AS OF CHANGE: 20200821 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cavan John T CENTRAL INDEX KEY: 0001503738 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36856 FILM NUMBER: 201123562 MAIL ADDRESS: STREET 1: C/O STEMLINE THERAPEUTICS, INC. STREET 2: 750 LEXINGTON AVENUE, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Hepion Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001583771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462783806 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 399 THORNALL STREET STREET 2: FIRST FLOOR CITY: EDISON STATE: NJ ZIP: 08837 BUSINESS PHONE: 732-902-4000 MAIL ADDRESS: STREET 1: 399 THORNALL STREET STREET 2: FIRST FLOOR CITY: EDISON STATE: NJ ZIP: 08837 FORMER COMPANY: FORMER CONFORMED NAME: ContraVir Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20130806 4 1 a4.xml 4 X0306 4 2020-08-19 0 0001583771 Hepion Pharmaceuticals, Inc. HEPA 0001503738 Cavan John T C/O HEPION PHARMACEUTICALS, INC. 399 THORNALL STREET, FIRST FLOOR EDISON NJ 08837 0 1 0 0 Chief Financial Officer Stock Options 3.72 2020-08-19 4 A 0 160000 0 A 2030-08-19 Common Stock 160000 381060 D 53,333 of the stock options vest on 8/19/2021 and the remainder vests monthly in equal amounts over 24 months. /s/ John Cavan 2020-08-21